Stakeholders are taking issue with the US Food and Drug Administration’s (FDA) draft guidance on conducting bioresearch monitoring (BIMO) inspections. They are particularly concerned about protecting ...
The US Food and Drug Administration (FDA) has issued two draft guidances on bioresearch monitoring (BIMO) inspections. The first covers information to assist the agency in planning these inspections, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results